Acasti Pharma Inc (NASDAQ:ACST) is falling a bit after gaining about 18% in yesterday’s trading session.
As of 9:50, ACST stock fell 1% to $0.5310. The stock has seen a total volume of 90 million shares, compared to its average volume of 14.88 million shares. The stock opened at $0.57 and moved in a wide range of $0.5055 – 0.5650.
ACST Released News Earlier This Week
Mon, 17 May, 2021 Acasti Intends to Request Hearing Before Nasdaq Panel to Present Plan of Compliance
- ACST announced that, on May 11, 2021, the Company received notice from the Nasdaq Listing Qualifications Department (the “Staff”) indicating that, based upon the Company’s non-compliance with the $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a) (the “Rule”) as of May 10, 2021, the Company’s securities were subject to delisting unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”).
- The Company has previously disclosed and expected such notification from Nasdaq and believes it has options to regain compliance, preferably in connection with its proposed acquisition of Grace Therapeutics, Inc. (“Grace”) as is often done in connection with similar transactions.
- The Company plans to timely request a hearing, which will stay any further action by Nasdaq pending the conclusion of the hearing process.
|SHARES OUTSTANDING||208.38 M|
|SHARE FLOAT (%)||207.83 M (99.74%)|
|% HELD BY INSTITUTIONS||0.92|
Recent Stock Performance
|+/- EMA(20)||0.48 (+10.42%)|
|+/- SMA(50)||0.54 (-1.85%)|
|+/- SMA(200)||0.47 (+12.77%)|
|CCI20||94.9854||Buy||Chaikin Money Flow||-0.2743||Sell|
|MACD||-0.0294||Sell||Money Flow Index||73.4144||Buy|
|STOCH (14,3)||63.8816||Buy||STOCH RSI||1.0000||OverBought|